Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Update on gastric cancer treatments and gene therapies.

Biagioni A, Skalamera I, Peri S, Schiavone N, Cianchi F, Giommoni E, Magnelli L, Papucci L.

Cancer Metastasis Rev. 2019 Sep 5. doi: 10.1007/s10555-019-09803-7. [Epub ahead of print] Review.

PMID:
31486976
2.

Stromal-induced mitochondrial re-education: Impact on epithelial-to-mesenchymal transition and cancer aggressiveness.

Bacci M, Ippolito L, Magnelli L, Giannoni E, Chiarugi P.

Semin Cell Dev Biol. 2019 May 22. pii: S1084-9521(18)30218-0. doi: 10.1016/j.semcdb.2019.05.009. [Epub ahead of print] Review.

PMID:
31108187
3.

Chemotherapy resistance-associated epithelial to endothelial transition in gastric cancer.

4° JOINT MEETING OF PATHOLOGY AND LABORATORY MEDICINE SIPMET–SIPMEL - SECOND JOINT MEETING IN COLLABORATION WITH ASIP–AMP–UEMS–WASPALM - 4° SIPMEL NATIONAL CONGRESS - 34° SIPMET NATIONAL CONGRESS - 4° CONGRESS OF PATHOLOGY AND LABORATORY MEDICINE, Peri S, Biagioni A, Cianchi F, Skalamera I, Staderini F, Schiavone N, Papucci L, Magnelli L.

J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4 Suppl. 1):30. No abstract available.

PMID:
30761866
4.

Serpin A1 and the modulation of type I collagen turnover: Effect of the C-terminal peptide 409-418 (SA1-III) in human dermal fibroblasts.

Cipriani C, Pascarella S, Errante F, Menicacci B, Magnelli L, Mocali A, Rovero P, Giovannelli L.

Cell Biol Int. 2018 Sep;42(10):1340-1348. doi: 10.1002/cbin.11018. Epub 2018 Jun 29.

PMID:
29908000
5.

Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma.

Lucarini L, Magnelli L, Schiavone N, Crisci A, Innocenti A, Puccetti L, Cianchi F, Peri S, Supuran CT, Papucci L, Masini E.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):234-240. doi: 10.1080/14756366.2017.1411350.

PMID:
29251173
6.

Roles of different IRES-dependent FGF2 isoforms in the acquisition of the major aggressive features of human metastatic melanoma.

Andreucci E, Bianchini F, Biagioni A, Del Rosso M, Papucci L, Schiavone N, Magnelli L.

J Mol Med (Berl). 2017 Jan;95(1):97-108. doi: 10.1007/s00109-016-1463-7. Epub 2016 Aug 24.

PMID:
27558498
7.

Atopic dermatitis is more severe in children over the age of two who have an increased body mass index.

Koutroulis I, Magnelli L, Gaughan J, Weiner E, Kratimenos P.

Acta Paediatr. 2015 Jul;104(7):713-7. doi: 10.1111/apa.12970. Epub 2015 Mar 11.

PMID:
25662159
8.

Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.

Mannelli G, Magnelli L, Deganello A, Busoni M, Meccariello G, Parrinello G, Gallo O.

Clin Otolaryngol. 2015 Aug;40(4):312-20. doi: 10.1111/coa.12368.

PMID:
25641707
9.

Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis.

Giusti B, Margheri F, Rossi L, Lapini I, Magi A, Serratì S, Chillà A, Laurenzana A, Magnelli L, Calorini L, Bianchini F, Fibbi G, Abbate R, Del Rosso M.

PLoS One. 2013 Jul 11;8(7):e68117. doi: 10.1371/journal.pone.0068117. Print 2013. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/b41766f2-c23d-455e-8d6e-e4bce5ae1d80.

10.

GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides.

Margheri F, Schiavone N, Papucci L, Magnelli L, Serratì S, Chillà A, Laurenzana A, Bianchini F, Calorini L, Torre E, Dotor J, Feijoo E, Fibbi G, Del Rosso M.

PLoS One. 2012;7(11):e50342. doi: 10.1371/journal.pone.0050342. Epub 2012 Nov 30.

11.

Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.

Serratì S, Chillà A, Laurenzana A, Margheri F, Giannoni E, Magnelli L, Chiarugi P, Dotor J, Feijoo E, Bazzichi L, Bombardieri S, Kahaleh B, Fibbi G, Del Rosso M.

Arthritis Rheum. 2013 Jan;65(1):258-69. doi: 10.1002/art.37705.

12.

Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae.

Margheri F, Chillà A, Laurenzana A, Serratì S, Mazzanti B, Saccardi R, Santosuosso M, Danza G, Sturli N, Rosati F, Magnelli L, Papucci L, Calorini L, Bianchini F, Del Rosso M, Fibbi G.

Blood. 2011 Sep 29;118(13):3743-55. doi: 10.1182/blood-2011-02-338681. Epub 2011 Jul 29.

PMID:
21803847
13.

Low doses of 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, stimulate angiogenesis by regulating expression of urokinase type plasminogen activator and matrix metalloprotease 2.

Caldini R, Fanti E, Magnelli L, Barletta E, Tanganelli E, Zampieri M, Chevanne M.

Vasc Cell. 2011 May 19;3(1):12. doi: 10.1186/2045-824X-3-12.

14.

Differentiating and apoptotic dose-dependent effects in (-)-alpha-bisabolol-treated human endothelial cells.

Magnelli L, Caldini R, Schiavone N, Suzuki H, Chevanne M.

J Nat Prod. 2010 Apr 23;73(4):523-6. doi: 10.1021/np9003933.

PMID:
20364847
15.

Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.

Cianchi F, Papucci L, Schiavone N, Lulli M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E, Romagnani P, Donnini M, Perigli G, Trallori G, Tanganelli E, Capaccioli S, Masini E.

Clin Cancer Res. 2008 Dec 1;14(23):7691-700. doi: 10.1158/1078-0432.CCR-08-0799.

16.

Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.

Cianchi F, Cortesini C, Magnelli L, Fanti E, Papucci L, Schiavone N, Messerini L, Vannacci A, Capaccioli S, Perna F, Lulli M, Fabbroni V, Perigli G, Bechi P, Masini E.

Mol Cancer Ther. 2006 Nov;5(11):2716-26.

17.

During muscle ageing the activation of the mitogenic signalling is not sufficient to guarantee cellular duplication.

Buricchi F, Chiarugi P, Fiaschi T, Giannoni E, Magnelli L, Fanti E, Raugei G, Ramponi G.

Ital J Biochem. 2005 Sep-Dec;54(3-4):258-67.

PMID:
16688935
18.

Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma.

Franchi A, Massi D, Santucci M, Masini E, Rossi Degl'Innocenti D, Magnelli L, Fanti E, Naldini A, Ardinghi C, Carraro F, Gallo O.

J Pathol. 2006 Feb;208(3):439-45.

PMID:
16278821
19.

The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer.

Cianchi F, Cortesini C, Schiavone N, Perna F, Magnelli L, Fanti E, Bani D, Messerini L, Fabbroni V, Perigli G, Capaccioli S, Masini E.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6807-15.

20.

Down-regulation of platelet-derived growth factor receptor signaling during myogenesis.

Fiaschi T, Chiarugi P, Buricchi F, Giannoni E, Taddei ML, Magnelli L, Cozzi G, Raugei G, Ramponi G.

Cell Mol Life Sci. 2003 Dec;60(12):2721-35.

PMID:
14685695
21.

Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma.

Gallo O, Schiavone N, Papucci L, Sardi I, Magnelli L, Franchi A, Masini E, Capaccioli S.

Am J Pathol. 2003 Aug;163(2):723-32.

22.

Lymphocyte function-associated antigen-1-mediated T cell adhesion is impaired by low molecular weight phosphotyrosine phosphatase-dependent inhibition of FAK activity.

Giannoni E, Chiarugi P, Cozzi G, Magnelli L, Taddei ML, Fiaschi T, Buricchi F, Raugei G, Ramponi G.

J Biol Chem. 2003 Sep 19;278(38):36763-76. Epub 2003 Jun 18.

23.

Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinomas.

Gallo O, Fabbroni V, Sardi I, Magnelli L, Boddi V, Franchi A.

Biochem Biophys Res Commun. 2002 Dec 13;299(4):517-24.

PMID:
12459168
24.

Brn-3a, a neuronal transcription factor of the POU gene family: indications for its involvement in cancer and angiogenesis.

Chiarugi V, Del Rosso M, Magnelli L.

Mol Biotechnol. 2002 Oct;22(2):123-7. Review.

PMID:
12405260
25.

Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential.

Dini G, Funghini S, Witort E, Magnelli L, Fanti E, Rifkin DB, Del Rosso M.

J Cell Physiol. 2002 Oct;193(1):64-72.

PMID:
12209881
26.

Multiple pathways of cell invasion are regulated by multiple families of serine proteases.

Del Rosso M, Fibbi G, Pucci M, D'Alessio S, Del Rosso A, Magnelli L, Chiarugi V.

Clin Exp Metastasis. 2002;19(3):193-207. Review.

PMID:
12067200
27.

Angiogenesis and the unique nature of tumor matrix.

Chiarug V, Ruggiero M, Magnelli L.

Mol Biotechnol. 2002 May;21(1):85-90. Review.

PMID:
11989661
28.

Apoptosis: molecular regulation of cell death and hematologic malignancies.

Chiarugi V, Cinelli M, Magnelli L, Dello SP.

Mol Biotechnol. 2002 Mar;20(3):305-14. Review.

PMID:
11936259
29.

Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis.

Franchi A, Gallo O, Paglierani M, Sardi I, Magnelli L, Masini E, Santucci M.

Head Neck. 2002 Jan;24(1):16-23.

PMID:
11774398
30.

Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.

Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M.

J Pathol. 2001 Jun;194(2):194-200.

PMID:
11400148
31.

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.

Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V, Masini E.

Neoplasia. 2001 Jan-Feb;3(1):53-61.

32.

Apoptosis : molecular regulation of cell death and hematologic malignancies.

Chiarugi V, Cinelli M, Magnelli L, Dello Sbarba P.

Methods Mol Med. 2001;55:323-38. doi: 10.1385/1-59259-074-8:323.

PMID:
21312115
33.

Regulation of urokinase/urokinase receptor interaction by heparin-like glycosaminoglycans.

Pucci M, Fibbi G, Magnelli L, Del Rosso M.

J Biol Chem. 2001 Feb 16;276(7):4756-65. Epub 2000 Nov 20.

34.

Molecular polarity in endothelial cells and tumor-induced angiogenesis.

Chiarugi V, Ruggiero M, Magnelli L.

Oncol Res. 2000;12(1):1-4. Review.

PMID:
11061339
35.

Tumor angiogenesis: thrombin and metalloproteinases in focus.

Chiarugi V, Magnelli L, Dello Sbarba P, Ruggiero M.

Exp Mol Pathol. 2000 Aug;69(1):63-6. Review. No abstract available.

PMID:
10891293
36.

Inhibitory effect of full-length human endostatin on in vitro angiogenesis.

Taddei L, Chiarugi P, Brogelli L, Cirri P, Magnelli L, Raugei G, Ziche M, Granger HJ, Chiarugi V, Ramponi G.

Biochem Biophys Res Commun. 1999 Sep 24;263(2):340-5.

PMID:
10491294
37.

Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFkappaB-dependent inducible nitric oxide synthase and cyclooxygenase-2.

Chiarugi V, Magnelli L, Chiarugi A, Gallo O.

J Cancer Res Clin Oncol. 1999 Aug-Sep;125(8-9):525-8. No abstract available.

PMID:
10480347
38.

Functional regulative pathways for p53, a protein of basic importance for the integrity of the cell genome.

Chiarugi V, Cinelli M, Magnelli L, Ruggiero M.

Mol Genet Metab. 1999 Jun;67(2):93-9. Review. No abstract available.

PMID:
10356307
39.

Role of p53 mutations in the radiosensitivity status of tumor cells.

Chiarugi V, Magnelli L, Cinelli M.

Tumori. 1998 Sep-Oct;84(5):517-20.

PMID:
9862508
40.

Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review).

Chiarugi V, Magnelli L, Gallo O.

Int J Mol Med. 1998 Dec;2(6):715-9. Review.

PMID:
9850741
41.

Oncogenes, p53, and tumor angiogenesis.

Chiarugi V, Magnelli L, Cinelli M, Ruggiero M.

J Cancer Res Clin Oncol. 1998;124(9):523-5. No abstract available.

PMID:
9808428
42.

Chronic treatment of human fibroblasts cultures with diacylglycerol induces down-regulation of p53 functional activity.

Magnelli L, Cinelli M, Chiarugi V.

Biochem Biophys Res Commun. 1998 Aug 10;249(1):222-5.

PMID:
9705861
43.

p53: radiosensitivity and antiangiogenic effects.

Chiarugi V, Cinelli M, Magnelli L.

Mol Genet Metab. 1998 May;64(1):7-11. Review. No abstract available.

PMID:
9682212
44.

Acetylation and phosphorylation of the carboxy-terminal domain of p53: regulative significance.

Chiarugi V, Cinelli M, Magnelli L.

Oncol Res. 1998;10(2):55-7.

PMID:
9666512
45.

Redundant down-regulation pathways for p53.

Cinelli M, Magnelli L, Chiarugi V.

Pharmacol Res. 1998 Feb;37(2):83-5. Review.

PMID:
9572060
46.

The old and the new in p53 functional regulation.

Magnelli L, Ruggiero M, Chiarugi V.

Biochem Mol Med. 1997 Oct;62(1):3-10. Review.

PMID:
9367792
47.

Complex interplay among apoptosis factors: RB, p53, E2F, TGF-beta, cell cycle inhibitors and the bcl2 gene family.

Chiarugi V, Magnelli L, Cinelli M.

Pharmacol Res. 1997 Apr;35(4):257-61. Review.

PMID:
9264039
48.

Senescence, immortalization and cancer.

Chiarugi V, Magnelli L.

Pharmacol Res. 1997 Feb;35(2):95-8. Review. No abstract available.

PMID:
9175575
49.

Regulation of p53 by protein kinase C during multi-stage carcinogenesis.

Magnelli L, Chiarugi V.

J Cancer Res Clin Oncol. 1997;123(7):365-9. Review. No abstract available.

PMID:
9260587
50.

In vitro modulation of MCF-7 breast cancer cell growth by myoepithelial cells.

Bani D, Magnelli L, Gallo O.

Int J Oncol. 1996 Jul;9(1):117-22.

PMID:
21541490

Supplemental Content

Loading ...
Support Center